Tuesday, February 4, 2020

Toronto-based BenchSci, which is using AI to accelerate drug discovery research and reduce related costs, raises $22M Series B led by F-Prime Capital (Kyle Wiggers/VentureBeat)

Kyle Wiggers / VentureBeat:
Toronto-based BenchSci, which is using AI to accelerate drug discovery research and reduce related costs, raises $22M Series B led by F-Prime Capital  —  Assessing the health of pharmaceutical R&D by unearthing hidden patterns in procurement data is a task made simpler by AI.



at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

The US Treasury says Robinhood and BNY will work with the federal government to handle tax-sheltered "Trump Accounts" for children when they launch this summer (Stacy Cowley/New York Times)

Stacy Cowley / New York Times : The US Treasury says Robinhood and BNY will work with the federal government to handle tax-sheltered “Tru...